Dr. Kundlik Gadhave

Postdoctoral fellow at University of Denver, USA.

[Dr. Kundlik Gadhave @KundlikG]

Delighted to receive this Award.

[Parkinson's Foundation Research @PFResearchTeam]

👏 Kicking it off with congrats to Postdoctoral Fellowship Awardee @KundlikG, who will explore biomarker and therapeutic development for alpha-synuclein strains using chemical fingerprinting 3D small molecule microarray @HopkinsMedicine
#Parkinsons

@ParkinsonDotOrg

[Parkinson's Foundation Research @PFResearchTeam]

👏 Kicking it off with congrats to Postdoctoral Fellowship Awardee @KundlikG, who will explore biomarker and therapeutic development for alpha-synuclein strains using chemical fingerprinting 3D small molecule microarray @HopkinsMedicine
#Parkinsons

@ParkinsonDotOrg

[Dr. Kundlik Gadhave @KundlikG]

Our preprint showing Lag3 as a specific receptor of pathologic Tau in the brain.

[bioRxiv @biorxivpreprint]

Pathological Tau transmission initiated by binding lymphocyte-activation gene 3 https://t.co/IQGN7BQcuB #bioRxiv

[Xiaobo Mao lab at Johns Hopkins @XiaoboMao]

I hope you find this paper interesting: Pathological Tau transmission initiated by binding lymphocyte-activation gene 3 https://t.co/pvcTKF1AVN

[Ramhari Kumbhar @kumbharramhari]

Excited to share our latest research work about disulfide bond free nanobodies that specifically recognizes a-Synuclein fibrils and reduce pathology. @XiaoboMao @KundlikG https://t.co/4a1xoUjdYL

[Dr. Kundlik Gadhave @KundlikG]

@PrateekGupta306 hi